Daniel Meling
MSc researcher affiliated with the Psychedelic Research & Therapy Development group at the University of Zurich / Psychiatric University Clinic Zurich
Key Impact
He is a recurring author on clinical and neuroimaging studies of DMT/harmine and meditation, contributing to some of the most visible contemporary psychedelic-mindfulness research.
Background & Research
Daniel Meling is a researcher working in psychedelic and contemplative science, with affiliations in psychiatry and psychosomatic medicine in Zurich and Freiburg. His work spans randomized controlled trials, pharmacokinetic/pharmacodynamic studies, and fMRI research on ayahuasca-inspired DMT/harmine formulations in mindfulness and meditation settings. He also publishes on psychedelics, meditation, and consciousness from an enactive/phenomenological perspective.
Collaboration Network
15 collaborators· click a node to visit their profile
Full network →